Medulloblastoma, the most commonly occurring malignant brain tumor in children, can be classified into four subgroups—each with a different risk profile requiring subgroup-specific therapy. Currently, subgroup determination is done after...
There's a serious need for pediatric medical devices - but little innovation in this market. The Sheikh Zayed Institute is working to change that.
Pediatric specific STTR funding opportunity - deadline July 15, 2015